Acciones LYSOGENE
Acciones
LYS
FR0013233475
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 52 | 01/01/09 | |
Director of Finance/CFO | - | 01/01/20 | |
Marie Trad
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/22 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Peter Lichtlen
BRD | Director/Board Member | 56 | 01/04/18 |
Michel Picot
BRD | Director/Board Member | 72 | - |
Chief Executive Officer | 52 | 01/01/09 |
Varia. 1 de ene. | Capi. | |
---|---|---|
-19,60 % | 11,29 mil M | |
+64,70 % | 3912,05 M | |
-31,09 % | 2293,88 M | |
-10,77 % | 2225,71 M | |
-26,86 % | 1607,69 M | |
+35,42 % | 1188,59 M | |
-2,40 % | 752 M | |
-35,10 % | 458 M | |
+14,91 % | 338 M |